Author: Belite Bio, Inc

Posted Date:

March 31, 2026

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

Belite Bio, Inc

March 31, 2026
Belite Bio to Participate in the Leerink Global Healthcare Conference

Belite Bio, Inc

March 2, 2026
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Belite Bio, Inc

March 2, 2026
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Belite Bio, Inc

February 23, 2026
Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)

Belite Bio, Inc

January 29, 2026
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)

Belite Bio, Inc

January 28, 2026